Subscribe

News|Articles|February 14, 2024

Developing a Robust Serialization Program

Author(s)Knipper

Various considerations can help pharmaceutical manufacturers and suppliers provide a robust serialization solution based on the FDA's Drug Supply Chain Security Act.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Content

De-Risking Clinical Development: Strategic Multipliers in Global Trials

December 4th 2025

Unlocking Financial and Operational Efficiencies in Clinical Trials: Modern Competitive Advantages in 2025

December 4th 2025

Rethinking Clinical Trial Data in the Era of Decentralization

November 24th 2025

Operationalizing DSCSA Compliance in the Warehouse

November 12th 2025

Temperature-Sensitive Innovations: A Cold Chain Outlook

November 12th 2025

Trending on Pharmaceutical Commerce

Advancing Circular Economy Packaging in Pharmaceutical Cold Chain

Pharma Pulse: The Access Gap

Körber Purchases Majority Stake in Stellium to Grow Global SAP Supply Chain Consulting Services

Building Trust in AI Supply Chains

FAQ: Decoding Alternative Funding Programs